APA (7th ed.) Citation

Hirano, M., Meyers, D., Golla, G., Pal, P., Pinot, P., Lin, T., . . . Chen, J. (2015). Effect of Hepatic Impairment on the Pharmacokinetics of Pradigastat, a Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor. Clinical pharmacokinetics, 54(7), 761-770. https://doi.org/10.1007/s40262-015-0235-9

Chicago Style (17th ed.) Citation

Hirano, Masaru, et al. "Effect of Hepatic Impairment on the Pharmacokinetics of Pradigastat, a Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor." Clinical Pharmacokinetics 54, no. 7 (2015): 761-770. https://doi.org/10.1007/s40262-015-0235-9.

MLA (9th ed.) Citation

Hirano, Masaru, et al. "Effect of Hepatic Impairment on the Pharmacokinetics of Pradigastat, a Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor." Clinical Pharmacokinetics, vol. 54, no. 7, 2015, pp. 761-770, https://doi.org/10.1007/s40262-015-0235-9.